ArticleFrontiers in neuroscience2017

AAV-Mediated Gene Supplementation Therapy in Achromatopsia Type 2: Preclinical Data on Therapeutic Time Window and Long-Term Effects.

Regine Mühlfriedel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.